Novartis is globally recognized for its innovative medicines. Novartis develops medicines that are protected by patents and sold on prescription only. These medicines meet the high health demands of patients, doctors and health organizations.
The Innovative Medicines division has a leading position in the company in terms of turnover and consists of several therapeutic areas:
1. Cardio-Metabolic and Respiratory
- Cardiology
- Diabetology
- Pneumology
2. Neuroscience, Immunology and Dermatology
- Neurology / psychiatry
- Immunology / dermatology / rheumatology / transplantology
3. Oncology
The business unit's portfolio provides cancer patients with a wide range of therapeutic and practical cancer treatment solutions, which are sub-divided into the following therapeutic areas:
Oncology
Haematology-oncology
4. In Market Brands